Fig. 4From: The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patientsKaplan–Meier analysis of the overall survival of the 105 BRAF-mutant advanced NSCLC patients treated with first-line chemotherapy. The risk table below illustrates the number of patients included per time pointBack to article page